NYLI Epoch International Choice Inv Cl holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
NYLI Epoch International Choice Investor Class ICELX
- NAV / 1-Day Return 52.61 / −1.52 %
- Total Assets 296.2M
-
Adj. Expense Ratio
1.520%
- Expense Ratio 1.520%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.28%
- Turnover 51%
USD | NAV as of Jun 11, 2026 | 1-Day Return as of Jun 11, 2026, 12:11 AM GMT+0
Morningstar’s Analysis ICELX
Will ICELX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ICELX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ICELX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Keyence Corp | 4.47 | 13M | Technology |
Taiwan Semiconductor Manufacturing Co Ltd ADR | 4.17 | 12M | Technology |
RELX PLC | 4.14 | 12M | Industrials |
Linde PLC | 4.03 | 12M | Basic Materials |
ING Groep NV | 3.87 | 11M | Financial Services |
TotalEnergies SE | 3.65 | 11M | Energy |
Samsung Electronics Co Ltd DR | 3.56 | 10M | Technology |
Vonovia SE | 3.48 | 10M | Real Estate |
Deutsche Post AG | 3.44 | 10M | Industrials |
AstraZeneca PLC | 3.38 | 10M | Healthcare |
United States